Neurovascular Stents-Medical Devices Pipeline Assessment, 2017
June 2017
70
About the Report
About the Report
Neurovascular Stents-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Neurovascular Stents-Medical Devices Pipeline Assessment, 2017" provides an overview of Neurovascular Stents currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Neurovascular Stents pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Neurovascular Stents under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Neurovascular Stents and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to-
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Neurovascular Stents under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Aneuclose LLC, Aneurysm Occlusion Saddle; Apeliotus Technologies, Polymer Stent for Cerebral Aneurysms; Codman &; Shurtleff Inc, Covered Stent; Codman &; Shurtleff Inc, Next Generation Balloon Expandable Stent; Codman &; Shurtleff Inc, Self-Expanding Stent; Cordis Corp, Flow Diverter; Gaudi Vascular, Inc., Intracranial Stent; MicroPort Scientific Corp, Vertebral Artery Stent; MicroVention, Inc., Coated Stent; MicroVention, Inc., FRED Flow-Diverting Stent; Neurosigma Inc, Thin Film Nitinol Flow Diverting Stent; NSVascular, Inc., Flow-Diverting TFN Stent; Palmaz Scientific Inc, Micro Neuro-Stent; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Flow Diversion Intracranial Stent; University of California Los Angeles, Dual Rotational Stent
Companies
Aneuclose LLC, Apeliotus Technologies, Codman & Shurtleff Inc, Cordis Corp, Gaudi Vascular, Inc., MicroPort Scientific Corp, MicroVention, Inc., Neurosigma Inc, NSVascular, Inc., Palmaz Scientific Inc, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of California Los Angeles
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Neurovascular Stents Overview 6
3 Products under Development 7
3.1 Neurovascular Stents-Pipeline Products by Stage of Development 7
3.2 Neurovascular Stents-Pipeline Products by Territory 8
3.3 Neurovascular Stents-Pipeline Products by Regulatory Path 9
3.4 Neurovascular Stents-Pipeline Products by Estimated Approval Date 10
3.5 Neurovascular Stents-Ongoing Clinical Trials 11
4 Neurovascular Stents-Pipeline Products under Development by Companies 12
4.1 Neurovascular Stents Companies-Pipeline Products by Stage of Development 12
4.2 Neurovascular Stents-Pipeline Products by Stage of Development 13
5 Neurovascular Stents Companies and Product Overview 14
5.1 Aneuclose LLC Company Overview 14
5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Apeliotus Technologies Company Overview 15
5.2.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Codman & Shurtleff Inc Company Overview 16
5.3.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Cordis Corp Company Overview 18
5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Gaudi Vascular, Inc. Company Overview 19
5.5.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 MicroPort Scientific Corp Company Overview 20
5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
5.7 MicroVention, Inc. Company Overview 21
5.7.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.8 Neurosigma Inc Company Overview 25
5.8.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 NSVascular, Inc. Company Overview 26
5.9.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Palmaz Scientific Inc Company Overview 27
5.10.1 Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 28
5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28
5.12 University of California Los Angeles Company Overview 29
5.12.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29
6 Neurovascular Stents- Recent Developments 30
6.1 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 30
6.2 Apr 23, 2017: Bard Announces First Quarter Results 31
6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 31
6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 33
6.5 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 36
6.6 Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes 37
6.7 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38
6.8 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 38
6.9 Jan 26, 2017: Bard Announces Fourth Quarter Results 40
6.10 Dec 15, 2016: MicroPort NeuroTech Attends CINS 2016 40
6.11 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 41
6.12 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 44
6.13 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 44
6.14 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 45
6.15 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 47
6.16 Oct 25, 2016: Bard Announces Third Quarter Results 49
6.17 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 50
6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 50
6.19 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 51
6.20 Aug 30, 2016: MPSC Announces 2016 Interim Results 52
6.21 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 53
6.22 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 56
6.23 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 58
6.24 Jul 26, 2016: Bard Announces Second Quarter Results 60
6.25 Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 61
6.26 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 61
6.27 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 61
6.28 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 62
6.29 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 62
6.30 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 63
7 Appendix 67
7.1 Methodology 67
7.2 About GlobalData 70
7.3 Contact Us 70
7.4 Disclaimer 70
List of Figure
1.2 List of Figures
Figure 1: Neurovascular Stents-Pipeline Products by Stage of Development 7
Figure 2: Neurovascular Stents-Pipeline Products by Territory 8
Figure 3: Neurovascular Stents-Pipeline Products by Regulatory Path 9
Figure 4: Neurovascular Stents-Pipeline Products by Estimated Approval Date 10
Figure 5: Neurovascular Stents-Ongoing Clinical Trials 11
List of Table
1.1 List of Tables
Table 1: Neurovascular Stents-Pipeline Products by Stage of Development 7
Table 2: Neurovascular Stents-Pipeline Products by Territory 8
Table 3: Neurovascular Stents-Pipeline Products by Regulatory Path 9
Table 4: Neurovascular Stents-Pipeline Products by Estimated Approval Date 10
Table 5: Neurovascular Stents-Ongoing Clinical Trials 11
Table 6: Neurovascular Stents Companies-Pipeline Products by Stage of Development 12
Table 7: Neurovascular Stents-Pipeline Products by Stage of Development 13
Table 8: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: Aneurysm Occlusion Saddle-Product Status 14
Table 10: Aneurysm Occlusion Saddle-Product Description 14
Table 11: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15
Table 12: Polymer Stent for Cerebral Aneurysms-Product Status 15
Table 13: Polymer Stent for Cerebral Aneurysms-Product Description 15
Table 14: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 15: Covered Stent-Product Status 16
Table 16: Covered Stent-Product Description 16
Table 17: Next Generation Balloon Expandable Stent-Product Status 16
Table 18: Next Generation Balloon Expandable Stent-Product Description 17
Table 19: Self-Expanding Stent-Product Status 17
Table 20: Self-Expanding Stent-Product Description 17
Table 21: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18
Table 22: Flow Diverter-Product Status 18
Table 23: Flow Diverter-Product Description 18
Table 24: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 25: Intracranial Stent-Product Status 19
Table 26: Intracranial Stent-Product Description 19
Table 27: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
Table 28: Vertebral Artery Stent-Product Status 20
Table 29: Vertebral Artery Stent-Product Description 20
Table 30: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 31: Coated Stent-Product Status 21
Table 32: Coated Stent-Product Description 21
Table 33: FRED Flow-Diverting Stent-Product Status 22
Table 34: FRED Flow-Diverting Stent-Product Description 22
Table 35: MicroVention, Inc.-Ongoing Clinical Trials Overview 23
Table 36: FRED Flow-Diverting Stent-Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms 24
Table 37: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 38: Thin Film Nitinol Flow Diverting Stent-Product Status 25
Table 39: Thin Film Nitinol Flow Diverting Stent-Product Description 25
Table 40: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
Table 41: Flow-Diverting TFN Stent-Product Status 26
Table 42: Flow-Diverting TFN Stent-Product Description 26
Table 43: Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 44: Micro Neuro-Stent-Product Status 27
Table 45: Micro Neuro-Stent-Product Description 27
Table 46: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: Flow Diversion Intracranial Stent-Product Status 28
Table 48: Flow Diversion Intracranial Stent-Product Description 28
Table 49: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: Dual Rotational Stent-Product Status 29
Table 51: Dual Rotational Stent-Product Description 29
Table 52: Glossary 69
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.